Affinity Asset Advisors, LLC Vera Therapeutics, Inc. Transaction History
Affinity Asset Advisors, LLC
- $596 Million
- Q2 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 545,000 shares of VERA stock, worth $16.1 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
545,000
Previous 355,143
53.46%
Holding current value
$16.1 Million
Previous $8.53 Million
50.53%
% of portfolio
2.15%
Previous 0.95%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Avoro Capital Advisors LLC New York, NY6.3MShares$187 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$133 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$101 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$99.1 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$98.8 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $801M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...